PeptidePedia The community reference

Active pharmaceutical ingredient (revision 3)

Old revision·00:08, 5 Dec 2024·CategoryBot

This is an old revision of this page, as it stood at 00:08, 5 Dec 2024, saved by CategoryBot with the summary bot: sort category members. It may differ substantially from the current revision, and any error it contains may since have been corrected.
Active pharmaceutical ingredient
AbbreviationAPI
Definition sourceICH Q7
Distinct fromExcipient; finished product
Registered inA drug master file in many jurisdictions
Topic infobox · conventions

An active pharmaceutical ingredient (API) is a substance intended to be used in the manufacture of a medicinal product and to furnish pharmacological activity in it. The term is a regulatory category rather than a chemical one: the same molecule is an API when destined for a medicine and is not when destined for laboratory research.[1]

That distinction determines which requirements apply. API manufacture is subject to GMP and to registration in many jurisdictions; the same chemistry performed for research supply is not.[1]

The regulatory frame

[edit]

Guidance for APIs covers the same ground as finished-product GMP, adapted to bulk substance: materials, process controls, validation, records, and the point in a process at which GMP begins to apply — which for a synthetic API is generally the introduction of the starting material into the process.[1]

Registration mechanisms vary. A drug master file allows a manufacturer to submit confidential process detail to a regulator and to authorise a customer to reference it; other jurisdictions use certificates of suitability or direct registration.

References

  1. ^ a b c International Council for Harmonisation, Q7: Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients (2000).